Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02343822 · ClinicalTrials.gov registry record · NA
Multiple Platelet-Rich Plasma Lateral Epidondylitis Injections Versus a Single Platelet-Rich Plasma Injection
A NA study, sponsored by Kaiser Permanente.
- Terminated
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT02343822 is a NA study that was terminated before completion, run by Kaiser Permanente. The registered enrollment target is 42 participants.
The verdict
NCT02343822, a NA study, was terminated before completion, sponsored by Kaiser Permanente.
- TERMINATED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
To determine the ideal dose of PRP for lateral epicondylitis. To see if 2 PRP injections are better than a single PRP injection or a saline injection to improve function and pain in patients with lateral epicondylitis.
Interventions
- OTHER Saline Injection
- OTHER Platelet Rich Plasma Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02343822
The ClinicalTrials.gov registry entry for NCT02343822 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline Injection is the first listed.
NCT02343822 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02343822 about?
NCT02343822 is a clinical study titled "Multiple Platelet-Rich Plasma Lateral Epidondylitis Injections Versus a Single Platelet-Rich Plasma Injection". To determine the ideal dose of PRP for lateral epicondylitis. To see if 2 PRP injections are better than a single PRP injection or a saline injection to improve function and pain in patients with lateral epicondylitis.
What is the current status of trial NCT02343822?
This trial is currently terminated. It is a NA study. The enrollment target is 42 participants. The study started on 2015-03. Estimated completion is 2016-09-20.
What interventions are being tested in trial NCT02343822?
The interventions under investigation include: Saline Injection (OTHER), Platelet Rich Plasma Injection (OTHER).
Who is sponsoring clinical trial NCT02343822?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.